November 29, 2019Catheterization and Cardiovascular Interventions
Perceval sutureless valve migration treated by valve‐in‐valve with a CoreValve Evolut Pro
Key result
Valve-in-valve treatment using a self-expanding TAVR device successfully treated massive aortic regurgitation due to early partial embolization of a Perceval valve.
Comparison
Valve-in-valve using a self-expanding TAVR device
Design
Case report
Authors
Discussion
Loading...
Member takes
Implication
May serve as bailout in rare Perceval embolization; leaves open need for prospective safety data.
Study Design
Type
Case Report (n=1)
Structured PICO
P
Population
A single case report of a patient with early partial embolization of a Perceval valve resulting in massive aortic regurgitation.
I
Intervention
Valve-in-valve procedure using a self-expanding TAVR device (CoreValve Evolut Pro)
O
Outcome
Successful treatment of para-valvular leak and aortic regurgitation
This case demonstrates the feasibility of using a self-expanding TAVR device for valve-in-valve treatment of early partial embolization of a sutureless aortic valve.
Cite This Study
Laricchia et al. (2019) conducted a case report in Perceval sutureless valve migration with massive aortic regurgitation (n=1). Valve-in-valve treatment using a self-expanding TAVR device (CoreValve Evolut Pro) was evaluated on Successful treatment of para-valvular leak with massive aortic regurgitation. Valve-in-valve treatment using a self-expanding TAVR device successfully treated massive aortic regurgitation due to early partial embolization of a Perceval valve.